Exosomal ephrinA2 derived from serum as a potential biomarker for prostate cancer

Up-regulation of serum ephrinA2 is common in various malignancies and has been suggested as a potential biomarker for the diagnosis and prognosis of prostate cancer (PCa). However, the type of serum ephrinA2 expressed in PCa patients remains elusive. Furthermore, the level of exosomal ephrinA2 deriv...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Shibao, Zhao, Yao, Chen, Wenbai, Yin, Lingyu, Zhu, Jie, Zhang, Haoliang, Cai, Chenchen, Li, Pengpeng, Huang, Lingyan, Ma, Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6072821/
https://www.ncbi.nlm.nih.gov/pubmed/30087706
http://dx.doi.org/10.7150/jca.25201

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6072821/
https://www.ncbi.nlm.nih.gov/pubmed/30087706
http://dx.doi.org/10.7150/jca.25201

Ejemplares similares